This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:Elizabeth Schneider
From Proteopedia
| Line 4: | Line 4: | ||
| - | N-acetylglucosamine (GlcNAc) phosphotransferase is a cis-Golgi-localized enzyme that recognizes the specific protein sequence in newly synthesized lysosomal enzymes and transfers phosphorylated GlcNAc | + | N-acetylglucosamine (GlcNAc) phosphotransferase is a cis-Golgi-localized enzyme that recognizes the specific protein sequence in newly synthesized lysosomal enzymes and transfers phosphorylated GlcNAc groups [Lodish, H. F., et al.]. Post-translational modifications occur via GlcNAc in the cytoplasm outside of the nucleus, including the protein glycosylation on serine and threonine residues [Bioconjugate Chem.]. |
| + | |||
| + | Any imbalance of phosphorylation can lead to diseases including cancer, diabetes, and neurodegenerative diseases. Management of phosphorylation and other modifications performed by GlcNAc can allow for better diagnoses and treatments of such diseases [Bioconjugate Chem.]. | ||
| + | |||
| + | |||
| + | |||
| + | Bioconjugate Chem., 2014, 25 (6), pp 1025–1030 | ||
| + | |||
| + | Lodish, H. F., et al. Molecular cell biology, 8th ed.; W.H. Freeman-Macmillan Learning: New York, 2016. | ||
Revision as of 04:18, 6 April 2019
N-acetylglucosamine phosphotransferase
Elizabeth Schneider and Samantha Templeton; Students; Erskine College, Due West, SC, United States
N-acetylglucosamine (GlcNAc) phosphotransferase is a cis-Golgi-localized enzyme that recognizes the specific protein sequence in newly synthesized lysosomal enzymes and transfers phosphorylated GlcNAc groups [Lodish, H. F., et al.]. Post-translational modifications occur via GlcNAc in the cytoplasm outside of the nucleus, including the protein glycosylation on serine and threonine residues [Bioconjugate Chem.].
Any imbalance of phosphorylation can lead to diseases including cancer, diabetes, and neurodegenerative diseases. Management of phosphorylation and other modifications performed by GlcNAc can allow for better diagnoses and treatments of such diseases [Bioconjugate Chem.].
Bioconjugate Chem., 2014, 25 (6), pp 1025–1030
Lodish, H. F., et al. Molecular cell biology, 8th ed.; W.H. Freeman-Macmillan Learning: New York, 2016.
